Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradley S. E., Chasis H., Goldring W., Smith H. W. HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION. J Clin Invest. 1945 Sep;24(5):749–758. doi: 10.1172/JCI101660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CRAVER B. N., BARRETT W., CAMERON A., YONKMAN F. F. The activities of 1-hydrazinophthalazine (Ba-5968); a hypotensive agent. J Am Pharm Assoc Am Pharm Assoc. 1951 Nov;40(11):559–564. doi: 10.1002/jps.3030401109. [DOI] [PubMed] [Google Scholar]
- Chasis H., Ranges H. A., Goldring W., Smith H. W. THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN. J Clin Invest. 1938 Sep;17(5):683–697. doi: 10.1172/JCI100996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FREIS E. D., FINNERTY F. A., Jr Suppression of vasomotor reflexes in man following L-hydrazinophthalozine (C-5968). Proc Soc Exp Biol Med. 1950 Oct;75(1):23–24. doi: 10.3181/00379727-75-18085. [DOI] [PubMed] [Google Scholar]
- FREIS E. D., MacKAY J. C., OLIVER W. F. The effect of sympatholytic drugs on the cardiovascular responses to epinephrine and norepinephrine in man. Circulation. 1951 Feb;3(2):254–259. doi: 10.1161/01.cir.3.2.254. [DOI] [PubMed] [Google Scholar]
- GROSS F., DRUEY J., MEIER R. Eine neue Gruppe blutdrucksenkender Substanzen von besonderem Wirkungscharakter. Experientia. 1950 Jan 15;6(1):19–21. doi: 10.1007/BF02154049. [DOI] [PubMed] [Google Scholar]
- REUBI F. C. Renal hyperemia induced in man by a new phthalazine derivative. Proc Soc Exp Biol Med. 1950 Jan;73(1):102–102. doi: 10.3181/00379727-73-17591. [DOI] [PubMed] [Google Scholar]
- Reubi F. C., Futcher P. H. THE EFFECTS OF HISTAMINE ON RENAL FUNCTION IN HYPERTENSIVE AND NORMOTENSIVE SUBJECTS. J Clin Invest. 1949 May;28(3):440–446. doi: 10.1172/JCI102088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHMID A., REUBI F. Hämodynamische Eigenschaften zweier neuer Phthalazinderivate. Helv Med Acta. 1950 Oct;17(4-5):543–546. [PubMed] [Google Scholar]
- SCHROEDER N. A. The effect of 1-hydrasinophthalasine in hypertension. Circulation. 1952 Jan;5(1):28–37. doi: 10.1161/01.cir.5.1.28. [DOI] [PubMed] [Google Scholar]
- TAYLOR R. D., PAGE I. H., CORCORAN A. C. A hormonal neurogenic vasopressor mechanism. AMA Arch Intern Med. 1951 Jul;88(1):1–8. doi: 10.1001/archinte.1951.03810070011001. [DOI] [PubMed] [Google Scholar]
- WALKER H. A., WILSON S., ATKINS E. C., GARRETT H. E., RICHARDSON A. P. The effect of 1-hydrazinophthalazine (C-5968) and related compounds on the cardiovascular system of dogs. J Pharmacol Exp Ther. 1951 Apr;101(4):368–378. [PubMed] [Google Scholar]
- YONKMAN F. F. Neurogenic hypertension; chemical approaches to its amelioration. J Mich State Med Soc. 1951 Feb;50(2):160–167. [PubMed] [Google Scholar]